AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice

作者：Jaerbe Torbjoern U C; Tai Sherrica; LeMay Brian J; Nikas Spyros P; Shukla Vidyanand G; Zvonok Alexander; Makriyannis Alexandros

来源：Psychopharmacology, 2012, 220(2): 417-426.

DOI：10.1007/s00213-011-2491-1

• Cannabinoid
• AM2389
• AM5983
• Delta(9)-THC
• AM251
• Hypothermia
• Drug discrimination
• Mice
• Rats

Rationale The endocannabinoid signaling system (ECS) has been targeted for developing novel therapeutics since ECS dysfunction has been implicated in various pathologies. Current focus is on chemical modifications of the hexahydrocannabinol (HHC) nabilone (Cesamet(A (R))).
Objectives To characterize the novel, high-affinity cannabinoid receptor 1 (CB1R) HHC-ligand AM2389 [9 beta-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol in two rodent pre-clinical assays.
Materials and methods CB1R mediation of AM2389-induced hypothermia in mice was evaluated with AM251, a CB1R-selective antagonist/inverse agonist. Additionally, two groups of rats discriminated the full cannabinergic aminoalkylindole AM5983 (0.18 and 0.56 mg/kg) from vehicle 20 min post-injection in a two-choice operant conditioning task motivated by 0.1% saccharin/water. Generalization/substitution tests were conducted with AM2389, AM5983, and Delta(9)-tetrahydrocannabinol (Delta(9)-THC).
Results Delta(9)-THC (30 mg/kg)-induced hypothermia exhibited a faster onset and shorter duration of action compared with AM2389 (0.1 and 0.3 mg/kg). AM251 (3 and 10 mg/kg) attenuated/blocked hypothermia induced by 0.3 mg/kg AM2389. In drug discrimination, the order of potency was AM2389 > AM5983 > Delta(9)-THC with ED50 values of 0.0025, 0.0571, and 0.2635 mg/kg, respectively, in the low-dose condition. The corresponding ED50 values in the high-dose condition were 0.0069, 0.1246, and 0.8438 mg/kg, respectively. Onset of the effects of AM2389 was slow with a protracted time-course; the functional, perceptual in vivo half-life was approximately 17 h.
Conclusions This potent cannabinergic HHC exhibited a slow onset of action with a protracted time-course. The AM2389 chemotype appears well suited for further drug development, and AM2389 currently is used to probe behavioral consequences of sustained ECS activation.

• 出版日期2012-3
• 单位东北大学